Dr Lim Hui Fang is a specialist in respiratory medicine and intensive care medicine, with a special interest in severe asthma, complex airway diseases and pneumonia.

She trained as a research fellow under Dr Parameswaran Nair in McMaster University, Canada and conducted research in the role of monoclonal antibodies in severe eosinophilic asthma/ COPD, bronchial thermoplasty, lung autoimmunity and lung microbiome in severe asthma.

Her research focuses on using airway inflammometry to study innate and adaptive immune mechanistic links between severe asthma, lung infections and obesity. She is in charge of the airway inflammometry service to phenotype severe asthma patients for selection for different novel treatment such as steroid-sparing biologics, Xolair and bronchial thermoplasty.

Research interests
Airway inflammometry, role of lung macrophages
Severe Asthma, corticosteroid resistance, effects of air pollution, lung microbiome
Complex airway disease (including chronic obstructive airway disease and bronchiectasis)
Pneumonia (use of severity tools or biomarkers for early diagnosis of severe cases)